Acute and Mid-Term Assessment of Microvascular Dysfunction with Index of Microcirculatory Resistance in ST-Segment

Shojiro Hirano1, Takayuki Yabe1, Yosuke Oka2

  • 1Department of Cardiovascular Medicine, Toho University Faculty of Medicine Graduate School of Medicine.

PubMed

Insights

Microvascular dysfunction (MVD) in ST-segment elevation myocardial infarction (STEMI) patients significantly improves by 6 months post-percutaneous coronary intervention (PCI). This midterm improvement in coronary microcirculation is linked to reduced MVD extent and shorter symptom-onset-to-balloon times.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Interventional Cardiology

Background:

  • Coronary microvascular dysfunction (MVD) persists in ST-segment elevation myocardial infarction (STEMI) patients post-percutaneous coronary intervention (PCI), despite normal epicardial artery patency.
  • Limited data exist on midterm microcirculation recovery using invasive measures.

Purpose of the Study:

  • To assess midterm microvascular function in STEMI patients using the index of microvascular resistance (IMR).
  • To evaluate changes in MVD from acute phase to 6 months post-PCI.

Main Methods:

  • Prospective evaluation of 41 STEMI patients undergoing PCI.
  • Invasive IMR measurement using a coronary pressure wire with adenosine infusion at 1 week and 6 months post-PCI.

Main Results:

  • IMR significantly improved from baseline (30.00) to midterm follow-up (19.00) (P=0.020).
  • The prevalence of MVD decreased significantly from 61.0% to 34.1% (P=0.016).
  • Midterm MVD was associated with elevated brain natriuretic peptide and prolonged symptom-onset-to-balloon time.

Conclusions:

  • Microvascular dysfunction in STEMI patients shows significant improvement 6 months after PCI.
  • Midterm MVD assessment is feasible and provides valuable prognostic information.
  • Early reperfusion strategies may positively impact midterm microvascular recovery.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
497
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
502